Good news~!!! R&D 100 Awards have served as the most prestigious innovation awards program for the past 56 years. Many scientists have considered the Awards as the R&D Oscar. The final awardee list of 2018 R&D100 will be announced in November this year. We are happy to announce that the cutting-edge NASK Nanofibrous Bacteria Killing[…]
Sarinda Kwok, Director of Profit Royal Pharmaceutical Limited, was invited on air on July 21, 2018 at the program 『智識做老闆』 to share innovation and technology of NASK Smart Mask. Interested parties may click below link listening the archive https://drive.google.com/file/d/1BILAKwy7msG8zoRwXRfeZdpfCPpNSZ9n/view?usp=sharing
2018 Hong Kong Top Brand & Top Service Brand Awards and Hong Kong Emerging Brand & Emerging Service Brand Awards Hong Kong Brand Development Council Kick-off Ceremony of 2018 Hong Kong Top Brand & Top Service Brand Awards and Hong Kong Emerging Brand & Emerging Service Brand Awards was held on July 17, 2018. Profit[…]
NASK will be attending the 5th South Africa TB Conference. One of the conference objectives is to look for preventive measures to combat TB infections in South Africa. The delegates including representatives from WHO, medical specialists and professionals dealing with TB patients and their families will share their clinical experiences and latest researches in Conference;[…]
Please be informed that the office will be closed from Feb. 16, 2018 to Feb. 22, 2018 for the Chinese Lunar New Year Holidays.We will be back to work on Feb. 23, 2018 (Friday).
We are pleased to announce that Profit Royal Pharmaceutical Limited is a supplier of China State Construction Engineering (Hong Kong) Limited (CSCE) (A member of China Overseas Holdings Ltd).To dedicate a comprehensive occupational safety and health protection among staffs, CSCE provides NASK Nanofibrous Masks for them to use at the construction sites.
We are pleased to announce that NASK has been shortlisted on the “2017 Hong Kong Emerging Brand Awards List”. For details please visit below link: http://www.hkbrand.org/en/event/3/page/3/brand/595?activePage=1&tab=114
Profit Royal Pharmaceutical Limited (PR) has applied for registration as the suppliers for the Hong Kong Hospital Authority (HA) early 2017. PR has been successfully passed the assessment and became the registered suppliers of HA with effective from Sept 5, 2017.